Effect of a lifestyle intervention program with energy-restricted Mediterranean diet and exercise on weight loss and cardiovascular risk factors: One-year results of the PREDIMED-Plus trial

Diabetes Care

Volumn 42, Issue 5, 2019, Pages 777-788

  Salas Salvadó, Jordi ^a,b   Díaz López, Andrés ^a,b   Ruiz Canela, Miguel ^b,c   Basora, Josep ^a,b,d   Fitó, Montse ^b,e   Corella, Dolores ^b,f   Serra Majem, Luís ^b,g   Wärnberg, Julia ^b,h   Romaguera, Dora ^b,i   Estruch, Ramon ^b,j   Vidal, Josep ^k,l,m   Alfredo Martinez J ^b,c,n   Arós, Fernando ^b,o   Vázquez, Clotilde ^b,p   Ros, Emilio ^b,j   Vioque, Jesús ^q,r   López Miranda, José ^b,s   Bueno Cavanillas, Aurora ^r,t   Tur, Josep A ^b,u   Tinahones, Francisco J ^b,h   Martín, Vicente ^r,v   Lapetra, José ^b,w   Pintó, Xavier ^b,x   Daimiel, Lidia ^y   Delgado Rodríguez, Miguel ^r,z   Matía, Pilar ^aa   Gómez Gracia, Enrique ^b,h   Díez Espino, Javier ^b,c,ab   Babio, Nancy ^a,b   Castañer, Olga ^b,e   Sorlí, José V ^b,f   Fiol, Miquel ^b,i   Zulet, María Ángeles ^b,c   Bulló, Mònica ^a,b   Goday, Albert ^b,e,j   Martínez González, Miguel Á ^b,c,ac   more..

^a INSTITUT D INVESTIGACIÓ SANITÀRIA PERE VIRGILI IISPV   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c UNIVERSITY OF NAVARRA   (Spain)

^d Research Institute University Primary Care IDIAP Jordi Gol   (Spain)

^e HOSPITAL DEL MAR   (Spain)

^f UNIVERSITY OF VALENCIA   (Spain)

^g UNIVERSITY OF LAS PALMAS DE GRAN CANARIA   (Spain)

^h UNIVERSITY OF MÁLAGA   (Spain)

ⁱ HOSPITAL UNIVERSITARIO SON ESPASES   (Spain)

^j UNIVERSITY OF BARCELONA   (Spain)

^k HOSPITAL CLÍNIC   (Spain)

^l INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

^m INSTITUTO DE SALUD CARLOS III   (Spain)

ⁿ IMDEA FOOD INSTITUTE   (Spain)

^o HOSPITAL TXAGORRITXU   (Spain)

^p HOSPITAL UNIVERSITARIO FUNDACIÓN JIMÉNEZ DÍAZ   (Spain)

^q MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^r CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^s HOSPITAL UNIVERSITARIO REINA SOFÍA   (Spain)

^t UNIVERSITY OF GRANADA   (Spain)

^u UNIVERSITAT DE LES ILLES BALEARS   (Spain)

^v UNIVERSITY OF LEÓN   (Spain)

^w Balearic Health Service   (Spain)

^x HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^y CSIC   (Spain)

^z UNIVERSITY OF JAÉN   (Spain)

^aa UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^ab Unidad de Patología Crónica Compleja Servicio de Pediatría y Áreas Específicas Hospital Universitario de Navarra Servicio Navarro de Salud Osasunbidea   (Spain)

^ac HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INTERLEUKIN 18; LEPTIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BODY WEIGHT CHANGE; BODY WEIGHT LOSS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLYCEMIC CONTROL; HEALTH PROMOTION; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTERVENTION STUDY; KINESIOTHERAPY; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; MEDITERRANEAN DIET; MULTICENTER STUDY; OBESITY; OUTCOME ASSESSMENT; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; THERAPY EFFECT; TRIACYLGLYCEROL BLOOD LEVEL; WAIST CIRCUMFERENCE; BEHAVIOR THERAPY; CALORIC RESTRICTION; CARDIOVASCULAR DISEASE; COMPLICATION; EXERCISE; FOLLOW UP; LIFESTYLE; METABOLIC SYNDROME X; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; RISK FACTOR;

AGED; BEHAVIOR THERAPY; BLOOD GLUCOSE; CALORIC RESTRICTION; CARDIOVASCULAR DISEASES; DIET, MEDITERRANEAN; EXERCISE; EXERCISE THERAPY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LIFE STYLE; MALE; METABOLIC SYNDROME; MIDDLE AGED; OBESITY; OVERWEIGHT; PREDIABETIC STATE; RISK FACTORS; WEIGHT LOSS;

EID: 85062162906     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc18-0836     Document Type: Article

References (33)

1. Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: a systematic review and meta-analysis. BMC Public Health 2009;9:88
2. Hruby A, Hu FB. The epidemiology of obesity:abigpicturepharmacoeconomics.2015;33: 673–689.
3. Pi-Sunyer X, Blackburn G, Brancati FL, et al.; Look AHEAD Research Group. Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the Look AHEAD trial. Diabetes Care 2007;30:1374–1383
4. Zomer E, Gurusamy K, Leach R, et al. Interventions that cause weight loss and the impact on cardiovascular risk factors: a systematic review and meta-analysis. Obes Rev 2016;17: 1001–1011
5. Knowler WC, Fowler SE, Hamman RF, et al.; Diabetes Prevention Program Research Group. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study. Lancet 2009;374:1677–1686
6. Wing RR; Look AHEAD Research Group. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. Arch Intern Med 2010;170:1566–1575
7. Wing RR, Lang W, Wadden TA, et al.; Look AHEAD Research Group. Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes. Diabetes Care 2011;34: 1481–1486
8. Ma C, Avenell A, Bolland M, et al. Effects of weight loss interventions for adults who are obese on mortality, cardiovascular disease, and cancer: systematic review and meta-analysis. BMJ 2017;359:j4849
9. Wing RR, Bolin P, Brancati FL, et al.; Look AHEAD Research Group. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369:145–154
10. Martínez-González MA, Salas-Salvadó J, Estruch R. Intensive lifestyle intervention in type 2 diabetes. N Engl J Med 2013;369:2357
11. Howard BV, Van Horn L, Hsia J, et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women’s Health Initiative Randomized Controlled Dietary Modification Trial. JAMA 2006;295:655–666
12. Foreyt JP, Salas-Salvado J, Caballero B, et al. Weight-reducing diets: are there any differences? Nutr Rev 2009;67(Suppl. 1):S99–S101
13. Martínez-González MA, Salas-Salvadó J, Estruch R, Corella D, Fitó M, Ros E; PREDIMED Investigators. Benefits of the mediterranean diet: insights from the PREDIMED study. Prog Cardiovasc Dis 2015;58:50–60
14. Esposito K, Kastorini C-M, Panagiotakos DB, Giugliano D. Mediterranean diet and weight loss: meta-analysis of randomized controlled trials. Metab Syndr Relat Disord 2011;9:1–12
15. Shai I, Schwarzfuchs D, Henkin Y, et al.; Dietary Intervention Randomized Controlled Trial (DIRECT) Group. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. N Engl J Med 2008;359:229–241
16. Mancini JG, Filion KB, Atallah R, Eisenberg MJ. Systematic review of the Mediterranean diet for long-term weight loss. Am J Med 2016;129:407–415.e4
17. Estruch R, Ros E, Salas-Salvadó J, et al.; PREDIMED Study Investigators. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med 2018;378:e34
18. Alberti KGMM, Eckel RH, Grundy SM, et al.; International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009;120: 1640–1645
19. Schröder H, Fitó M, Estruch R, et al. A short screener is valid for assessing Mediterranean diet adherence among older Spanish men and women. J Nutr 2011;141:1140–1145
20. Molina L, Sarmiento M, Peñafiel J, et al. Validation of the Regicor short physical activity questionnaire for the adult population. PLoS One 2017;12:e0168148
21. Martínez-González MA, López-Fontana C, Varo JJ, Sánchez-Villegas A, Martinez JA. Validation of the Spanish version of the physical activity questionnaire used in the Nurses’ Health Study and the Health Professionals’ Follow-up Study. Public Health Nutr 2005;8:920–927
22. Jones CJ, Rikli RE, Beam WCA. A 30-s chair-stand test as a measure of lower body strength in community-residing older adults. Res Q Exerc Sport 1999;70:113–119
23. Sacks FM, Bray GA, Carey VJ, et al. Comparison of weight-loss diets with different compositions of fat, protein, and carbohydrates. N Engl J Med 2009;360:859–873
24. Franz MJ, VanWormer JJ, Crain AL, et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. J Am Diet Assoc 2007;107:1755–1767
25. Johnston BC, Kanters S, Bandayrel K, et al. Comparison of weight loss among named diet programs in overweight and obese adults: a meta-analysis. JAMA 2014;312:923–933
26. Leung AWY, Chan RSM, Sea MMM, Woo J. An overview of factors associated with adherence to lifestyle modification programs for weight management in adults. Int J Environ Res Public Health 2017;14
27. Mansoor N, Vinknes KJ, Veierød MB, Retterstøl K. Effects of low-carbohydrate diets v. low-fat diets on body weight and cardiovascular risk factors: a meta-analysis of rand-omised controlled trials. Br J Nutr 2016;115: 466–479
28. Estruch R, Martínez-González MA, Corella D, et al.; PREDIMED Study Investigators. Effects of a Mediterranean-style diet on cardiovascular risk factors: a randomized trial. Ann Intern Med 2006;145:1–11
29. Correia ML de G, Haynes WG. Leptin, obesity and cardiovascular disease. Curr Opin Neph-rol Hypertens 2004;13:215–223
30. Zilverschoon GRC, Tack CJ, Joosten LAB, Kullberg BJ, van der Meer JWM, Netea MG. Interleukin-18 resistance in patients with obesity and type 2 diabetes mellitus. Int J Obes 2008; 32:1407–1414
31. Schernthaner G-H, Kopp H-P, Kriwanek S, et al. Effect of massive weight loss induced by bariatric surgery on serum levels of interleukin-18 and monocyte-chemoattractant-protein-1 in morbid obesity. Obes Surg 2006;16:709–715
32. Kanda H, Tateya S, Tamori Y, et al. MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest 2006;116: 1494–1505
33. Gerszten RE, Garcia-Zepeda EA, Lim YC, et al. MCP-1 and IL-8 trigger firm adhesion of monocytes to vascular endothelium under flow conditions. Nature 1999;398:718–723